Adalimumab barriers to uptake: results of national survey

NHS England commissioned NHS Commissioning Support Units as a collaborative to develop and complete a survey of a sample of NHS Trusts to identify the barriers to update of biosimilars, with a focus on CCG commissioned biosimilars.

The documents on this page describe the process followed and present the results on this work.  They include:

  • A pre-survey pilot questionnaire undertaken in the North region
  • Results from a national survey of CCGs
  • Results from a national survey of NHS Trusts
  • An executive summary of the work in totality
AdalimumabBiosimilar medicineNewsRMOC medicines optimisation recommendations and resourcesRMOC recommendations and resources

Attachments